RituximabPersistent COVID-19 pneumonia: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1899卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12312-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：340 / 340

相关论文

共 50 条

[1] RituximabPersistent COVID-19 infection: case report
Reactions Weekly, 2022, 1900 (1) : 296 - 296
[2] Dexamethasone/temozolomideCOVID-19 and COVID-19 pneumonia: 5 case reports
Reactions Weekly, 2021, 1857 (1) : 131 - 131
[3] Prednisone/rituximabPersistent COVID-19 infection: case report
Reactions Weekly, 2025, 2040 (1) : 844 - 844
[4] AntineoplasticsCytopenia and COVID-19 pneumonia: 10 case reports
Reactions Weekly, 2021, 1851 (1) : 36 - 36
[5] ImmunosuppressantsCOVID-19 and COVID-19 pneumonia: 3 case reports
Reactions Weekly, 2022, 1934 (1) : 230 - 230
[6] RituximabRelapse or exacerbation of COVID-19 pneumonia: 4 case reports
Reactions Weekly, 2022, 1889 (1) : 280 - 280
[7] RituximabSevere arthralgias and COVID-19 pneumonia: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 388 - 388
[8] Multiple drugsCOVID-19 and COVID-19 pneumonia: 4 case reports
Reactions Weekly, 2021, 1858 (1) : 258 - 258
[9] Covid-19 vaccineLack of efficacy: 5 case reports
Reactions Weekly, 2022, 1918 (1) : 163 - 163
[10] Multiple drugsLack of efficacy and covid-19: 5 case reports
Reactions Weekly, 2025, 2043 (1) : 243 - 243

← 1 2 3 4 5 →